Condition: Pregnancy Related · Pregnancy Complications · Pregnancy, High Risk · Sponsor: Sumitomo Pharma Switzerland GmbH
The Relugolix Pregnancy Registry is a prospective, observational cohort study designed to evaluate the association between relugolix-containing therapy exposure during pregnancy and subsequent maternal, fetal, and infant outcomes. Data will be collected from enrolled pregnant women and the healthcare providers (HCPs) involved in their care or the care of their infants, if applicable.
This description comes directly from the study's public registry record.
Clinical Trials at Myovant · 650-278-8743 · ClinicalTrials@Myovant.com
Myovant Medical Monitor Study Director
Always discuss trial participation with your own doctor first.
| PPD | Wilmington, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05739123